[1] SONG Jian YUAN Minhui CUI Binghui CHU Yupeng MENG KaiqiangHUANG Yujuan HUI Jianping LIU Zhenghui WANG Jiehong SHEN Shuwen,.Intervention of Jinguo Weikang Capsule on Wnt/Lgr5 Signal Pathway in PLGC Rats [J]. Journal of Shaanxi University of Traditional Chinese Medicine, 2022, (05): 102-108. [doi: 10.13424/j.cnki.jsctcm.2022.05.020]
Copy

Intervention of Jinguo Weikang Capsule on Wnt/Lgr5 Signal Pathway in PLGC Rats

References:

[1]王宁,刘硕,杨雷,等.2018全球癌症统计报告解读[J].肿瘤综合治疗电子杂志,2019,5(1):87-97.
[2]蔺焕萍,王峰,周晓燕,等.李守朝教授治疗胃癌前病变临证经验拾萃[J].陕西中医,2021,42(1):103-105.
[3]杨宏升.安胃活血汤联合序贯法治疗慢性萎缩性胃炎胃癌前病变疗效研究[J].陕西中医,2019,40(9):1195-1198.
[4]王爱红,黄兰燕,米志宽.中药抑制胃癌肿瘤细胞增殖研究进展[J].陕西中医,2018,39(3):403-405.
[5]张兴旺,马艳梅,朱静.早期胃癌及癌前病变组织中LC3、Ki67、SOX9的表达及临床意义[J].陕西医学杂志,2020,49(11):1519-1522.
[6]宋成鑫,葛信国,储晶.养阴健脾散毒法辅助化疗治疗晚期胃癌临床研究[J].陕西中医,2020,41(11):1543-1547.
[7]安静,杨晋翔,魏玥,等.消痞颗粒对胃癌前病变大鼠p16基因甲基化的干预研究[J].世界中西医结合杂志,2019,14(12):1645-1648.
[8]杨洁,范引科,宋延平,等.扶脾化瘤饮诱导胃癌小鼠细胞凋亡和相关凋亡基因表达的机制研究[J].陕西中医,2019,40(5):550-552,590.
[9]曾进浩.健脾化瘀解毒方调控Wnt通路介导胃癌前病变大鼠Lgr5+细胞的机制研究[D].广州:广州中医药大学,2016.
[10]曾进浩,潘华峰,刘友章,等.胃痞消对胃癌前病变大鼠胃黏膜组织病理学的影响[J].广州中医药大学学报,2014,31(5):6.
[11]曾进浩,潘华峰,刘友章,等.胃炎Ⅰ号对胃癌前病变大鼠Wnt信号通路Wnt1,Wnt3a,CyclinD1表达的影响[J].中药新药与临床药理,2014,25(4):397-401.
[12]蔡甜甜,潘华峰,张成哲,等.基于TGFβ/Smads信号通路探讨胃痞消逆转GPL大鼠胃黏膜EMT效应机制[J].中药新药与临床药理,2017,28(4):424-429.
[13]刘伟,潘华峰,赵自明,等.健脾化瘀解毒方调控Wnt/βcatenin/GSK3β通路抑制胃癌前病变大鼠Lgr5+癌干细胞早期转移机制研究[J].中华中医药杂志,2017,32(5):1952-1956.
[14]叶景阳,朱西杰,王儒,等.复方蜥蜴散不同微粒组合剂对胃癌前病变模型大鼠Wnt信号通路下游CMyc、CyclinD1蛋白表达的影响[J].时珍国医国药,2016,27(7):1572-1575.
[15]Barker N,van Es JH,Kuipers J,et al.Identification of stem cells in small intestine and colon by marker gene Lgr5[J].Nature,2007,449(7165):1003-1007.
[16]Barker N,Huch M,Kujala P,et al.Lgr5+ve stem cells drive selfrenewal in the stomach and build longlived gastric units in vitro[J].Cell Stem Cell,2010,6(1):25-36.
[17]Gostjeva EV,Zukerberg L,Chung D,et al.Bellshaped nuclei dividing by symmetrical and asymmetrical nuclear fission have qualities of stem cells in human colonic embryogenesis and carcinogenesis[J].Cancer Genetics and Cytogenetics,2006,164(1):16-24.
[18]文娜,胡运莲.Lgr5、TFF2在萎缩性胃炎及低级别上皮内瘤变中的表达及临床意义[J].中国现代医生,2019,57(12):20-23,169.
[19]刘伟.胃痞灵调控mTOR/HIF1 α/SIRT6信号通路介导胃癌前病变有氧糖酵解的分子机制研究[D].广州:广州中医药大学,2019.
[20]石颖鹏,王敏娟,李程亮.肠化生相关分子与胃癌的发生和进展研究概况[J].陕西医学杂志,2019,48(7):958-961.
[21]沈舒文,宇文亚,汶明奇,等.金果胃康胶囊治疗胃癌前病变的临床观察[J].中医药学刊,2005,23(1):73-74,83.
[22]王捷虹,宇文亚,惠建萍.沈舒文教授毒瘀交阻理论辨治胃癌前病变经验[J].中华中医药杂志,2013,28(7):2034-2036.
[23]惠建萍,沈舒文,刘力,等.从“毒瘀交阻”理论辨治胃癌前病变的思路与方法[J].世界科学技术(中医药现代化),2012,14(1):1270-1272.
[24]Shen SW,Yu WY,Zhang ZL,et al.Effect of Jinguo Weikang Capsule(金果胃康胶囊)on protooncogene expression of gastric mucosa in rats with gastric precancerous lesions[J].Chinese Journal of Integrative Medicine,2008,(3):212-216.
[25]白苇,沈舒文,王婕红,等.金果胃康胶囊治疗胃黏膜异型增生60例临床观察[J].吉林中医药,2008,28(4):268-269.
[26]黄毓娟,沈舒文,宋健,等.金果胃康胶囊治疗胃黏膜上皮内瘤变患者的临床研究[J].中国临床药理学杂志,2020,36(5):486-489.
[27]黄毓娟,沈舒文,惠建平,等.人乳头瘤病毒16 E6蛋白通过Wnt/β-catenin通路促进食管癌Eca109细胞增殖、迁移的实验研究[J].病毒学报,2020,36(2):255-261.

Memo

基金项目:陕西省教育厅专项科学研究计划项目(18JK0225);陕西中医药大学科研计划项目(2017PY0国家级大学生创新创业训练计划项目(201910716024)

Last Update: 2022-09-23
Copyright @ 2020 Journal of Shaanxi University of Chinese Medicine
 Address: Middle Section of Century Avenue, Xianyang, Shaanxi Province. Post Code: 712046
Tel: 029-38185250 Fax: 029-38185250 E-mail: shxzhzs@163.com Powered by: www.editorhome.cn